Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT03293524
REFLECT
Efficacy & Safety Study of Bilateral Intravitreal Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year (REFLECT).
Type: Interventional
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: Yes
Inclusion
- Opening Date: 2018-12-20
- Closing Date: 2024-06-01
Criteria
Children: Yes
Adults: Yes
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Neuro-Ophthalmology Rare Diseases (WG2)
This ERN is supported by:
